Electromagnetic pulse exposure induces overexpression of beta amyloid protein in rats

Archives of Medical Research

Volumn 44, Issue 3, 2013, Pages 178-184

  Jiang, Da Peng ^a   Li, Jing ^a   Zhang, Jie ^a   Xu, Sheng Long ^a   Kuang, Fang ^a   Lang, Hai Yang ^a   Wang, Ya Feng ^a   An, Guang Zhou ^a   Li, Jin Hui ^a   Guo, Guo Zhen ^a,b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Alzheimer disease; Amyloid beta peptides; Autophagy; Electromagnetic fields; Oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; GLUTATHIONE; MICROTUBULE ASSOCIATED PROTEIN 1; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ASSESSMENT; COGNITIVE DEFECT; CONTROLLED STUDY; ELECTROMAGNETIC FIELD; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; MALE; MEMORY DISORDER; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

EID: 84876856475     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2013.03.005     Document Type: Article

References (34)

1. Brookmeyer R., Johnson E., Ziegler-Graham K., et al. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 2007, 3:186-191.
2. Feychting M., Jonsson F., Pedersen N.L., et al. Occupational magnetic field exposure and neurodegenerative disease. Epidemiology 2003, 14:413-419. discussion 427-418.
3. Harmanci H., Emre M., Gurvit H., et al. Risk factors for Alzheimer disease: a population-based case-control study in Istanbul, Turkey. Alzheimer Dis Assoc Disord 2003, 17:139-145.
4. Park R.M., Schulte P.A., Bowman J.D., et al. Potential occupational risks for neurodegenerative diseases. Am J Ind Med 2005, 48:63-77.
5. Huss A., Spoerri A., Egger M., et al. Residence near power lines and mortality from neurodegenerative diseases: longitudinal study of the Swiss population. Am J Epidemiol 2009, 169:167-175.
6. Ding G.R., Qiu L.B., Wang X.W., et al. EMP-induced alterations of tight junction protein expression and disruption of the blood-brain barrier. Toxicol Lett 2010, 196:154-160.
7. Chen Y.B., Li J., Liu J.Y., et al. Effect of electromagnetic pulses (EMP) on associative learning in mice and a preliminary study of mechanism. Int J Radiat Biol 2011, 87:1147-1154.
8. Ding G.R., Li K.C., Wang X.W., et al. Effect of electromagnetic pulse exposure on brain micro vascular permeability in rats. Biomed Environ Sci 2009, 22:265-268.
9. Qiu L.B., Ding G.R., Li K.C., et al. The role of protein kinase C in the opening of blood-brain barrier induced by electromagnetic pulse. Toxicology 2010, 273:29-34.
10. Qiu L.B., Ding G.R., Zhang Y.M., et al. Effects of electromagnetic pulse on blood-brain barrier permeability and tight junction proteins in rats. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2009, 27:539-543.
11. Wang X.W., Ding G.R., Shi C.H., et al. Mechanisms involved in the blood-testis barrier increased permeability induced by EMP. Toxicology 2010, 276:58-63.
12. Vorhees C.V., Williams M.T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 2006, 1:848-858.
13. Tanida I., Ueno T., Kominami E. Human light chain 3/MAP1LC3B is cleaved at its carboxyl-terminal Met121 to expose Gly120 for lipidation and targeting to autophagosomal membranes. J Biol Chem 2004, 279:47704-47710.
14. Kabeya Y., Mizushima N., Ueno T., et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000, 19:5720-5728.
15. He H., Dang Y., Dai F., et al. Post-translational modifications of three members of the human MAP1LC3 family and detection of a novel type of modification for MAP1LC3B. J Biol Chem 2003, 278:29278-29287.
16. Wu J., Dang Y., Su W., et al. Molecular cloning and characterization of rat LC3A and LC3B-two novel markers of autophagosome. Biochem Biophys Res Commun 2006, 339:437-442.
17. Ichimura Y., Kirisako T., Takao T., et al. A ubiquitin-like system mediates protein lipidation. Nature 2000, 408:488-492.
18. Kabeya Y., Mizushima N., Yamamoto A., et al. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J Cell Sci 2004, 117:2805-2812.
19. Grundke-Iqbal I., Iqbal K., George L., et al. Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease. Proc Natl Acad Sci USA 1989, 86:2853-2857.
20. Glenner G.G., Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984, 120:885-890.
21. Heras-Sandoval D., Ferrera P., Arias C. Amyloid-beta protein modulates insulin signaling in presynaptic terminals. Neurochem Res 2012, 37:1879-1885.
22. Chin J.H., Ma L., MacTavish D., et al. Amyloid beta protein modulates glutamate-mediated neurotransmission in the rat basal forebrain: involvement of presynaptic neuronal nicotinic acetylcholine and metabotropic glutamate receptors. J Neurosci 2007, 27:9262-9269.
23. Hernandez P., Lee G., Sjoberg M., et al. Tau phosphorylation by cdk5 and Fyn in response to amyloid peptide Abeta (25-35): involvement of lipid rafts. J Alzheimers Dis 2009, 16:149-156.
24. Querfurth H.W., LaFerla F.M. Alzheimer's disease. N Engl J Med 2010, 362:329-344.
25. Leuner K., Muller W.E., Reichert A.S. From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease. Mol Neurobiol 2012, 46:186-193.
26. Murakami K., Shimizu T. Cytoplasmic superoxide radical: a possible contributing factor to intracellular Abeta oligomerization in Alzheimer disease. Commun Integr Biol 2012, 5:255-258.
27. Murakami K., Murata N., Noda Y., et al. Stimulation of the amyloidogenic pathway by cytoplasmic superoxide radicals in an Alzheimer's disease mouse model. Biosci Biotechnol Biochem 2012, 76:1098-1103.
28. Gwon A.R., Park J.S., Arumugam T.V., et al. Oxidative lipid modification of nicastrin enhances amyloidogenic gamma-secretase activity in Alzheimer's disease. Aging Cell 2012, 11:559-568.
29. Kimura S., Fujita N., Noda T., et al. Monitoring autophagy in mammalian cultured cells through the dynamics of LC3. Methods Enzymol 2009, 452:1-12.
30. Dai D.F., Rabinovitch P. Mitochondrial oxidative stress mediates induction of autophagy and hypertrophy in angiotensin-II treated mouse hearts. Autophagy 2011, 7:917-918.
31. Nixon R.A., Wegiel J., Kumar A., et al. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol 2005, 64:113-122.
32. Jellinger K.A., Stadelmann C. Problems of cell death in neurodegeneration and Alzheimer's Disease. J Alzheimers Dis 2001, 3:31-40.
33. Brunk U.T., Terman A. The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur J Biochem 2002, 269:1996-2002.
34. Nixon R.A. A " protease activation cascade" in the pathogenesis of Alzheimer's disease. Ann N Y Acad Sci 2000, 924:117-131.